EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial

Alexandra J Lansky, Bo Xu, Andreas Baumbach, Henning Kelbæk, Niels van Royen, Ming Zheng, Paul Knaapen, Ton Slagboom, Thomas W Johnson, Georgios J Vlachojannis, Karin E Arkenbout, Lene Holmvang und 15 weitere

EuroIntervention · 2023-12 · 19 (10) · e844-e855

DOI: 10.4244/eij-d-23-00409 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift EuroIntervention, 2023-12. Verfasst von Alexandra J Lansky und 26 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cardiovascular Research Group, Yale School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Percutaneous Coronary Intervention, Myocardial Infarction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsPercutaneous Coronary InterventionMyocardial InfarctionHumansSirolimusProspective StudiesTreatment OutcomeAbsorbable ImplantsEverolimusPolymers

Substanzen

SirolimusEverolimusPolymers

Autor:innen und Institutionen

  • Yale Cardiovascular Research Group, Yale School of Medicine, New Haven, CT, USA.
  • Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Barts Heart Centre and Queen Mary University of London, London, United Kingdom.
  • Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.
  • Department of Cardiology, VU University Medical Centre, Amsterdam, the Netherlands.
  • Shanghai MicroPort Medical (Group) Co., Ltd. Shanghai, China.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Lansky, A. J., Xu, B., Baumbach, A., Kelbæk, H., van Royen, N., Zheng, M., Knaapen, P., Slagboom, T., Johnson, T. W., Vlachojannis, G. J., Arkenbout, K. E., Holmvang, L., Janssens, L., Brugaletta, S., Naber, C. K., Schmitz, T., Anderson, R., Rittger, H., Berti, S., …, & Wijns, W. (2023). Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial. EuroIntervention, 19(10), e844-e855. https://doi.org/10.4244/eij-d-23-00409

Vancouver

Lansky AJ, Xu B, Baumbach A, Kelbæk H, van Royen N, Zheng M, et al. Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial. EuroIntervention. 2023;19(10):e844-e855. doi:10.4244/eij-d-23-00409

BibTeX
@article{Lansky2023,
  author = {Lansky, Alexandra J and Xu, Bo and Baumbach, Andreas and Kelbæk, Henning and van Royen, Niels and Zheng, Ming and Knaapen, Paul and Slagboom, Ton and Johnson, Thomas W and Vlachojannis, Georgios J and Arkenbout, Karin E and Holmvang, Lene and Janssens, Luc and Brugaletta, Salvatore and Naber, Christoph K and Schmitz, Thomas and Anderson, Richard and Rittger, Harald and Berti, Sergio and Barbato, Emanuele and Toth, Gabor G and Maillard, Luc and Valina, Christian M and Buszman, Paweł E and Thiele, Holger and Schächinger, Volker and Wijns, William},
  title = {Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial},
  journal = {EuroIntervention},
  year = {2023},
  volume = {19},
  number = {10},
  pages = {e844--e855},
  doi = {10.4244/eij-d-23-00409}
}
Kostenlos starten →